HomePink SheetScripMedtech InsightHBW InsightGenerics BulletinIn Vivo

Spotlight

GLP-1s
Interviews
FDA
Strategy
Generics
Biosimilars
Value Added Medicines

Business

Deals
Earnings
Manufacturing

Policy & Regulation

Regulatory Landscape
Drug Pricing
IP & Litigation

Tools & Trackers

What's Next?
Who's Hired?
UK Pricing Tracker
Company Rankings

Conference Coverage

Partner Insights

Generics Bulletin Perspectives

Exploring market-shifting topics for the off-patent sector.

Medtech Insight

Generics Bulletin

Samsung Snags Second Soliris Biosimilar In US

Jul 23 2024

• By David Wallace

Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

Related Content

Pfizer Buys Arena For $6.7bn In Bid To Diversify In Inflammation & Immunology

Dec 13 2021

Pfizer Finally Wins English Funding For Sickle Cell Drug Oxbryta After Bumpy Ride

May 06 2024

More from Biosimilars

More from Pink Sheet

Twitter feed RSS feed RSS feed

About

About UsOpens in new window
Meet the Team
AdvertiseOpens in new window
Contact Us

Account

My Account
My View
Email Preferences
Start Free TrialOpens in new window

More

Generics Top 50 Ranking
Biosimilars
Generics
Value Added Medicines

Terms and Conditions Opens in new window

Privacy PolicyOpens in new window